Use of isoquinoline derivatives for treating cancer and MAP kinase related diseases

Details for Australian Patent Application No. 2004218914 (hide)

Owner Novartis AG

Inventors Batt, David Bryant; Bold, Guido; Kim, Sunkyu; Ramsey, Timothy Michael; Sabio, Michael Lloyd

Agent Davies Collison Cave

Pub. Number AU-A-2004218914

PCT Pub. Number WO2004/080464

Priority 60/453,624 11.03.03 US

Filing date 10 March 2004

Wipo publication date 23 September 2004

International Classifications

A61K 031/4725

A61P 035/00 Antineoplastic agents

A61K 031/472 - Non-condensed isoquinolines, e.g. papaverine

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080464 Priority application(s): WO2004/080464

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218919-Method and apparatus for removing dust from a workpiece

2004218913-Use of recombinant albumin in dialysis after liver failure